These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8545121)
1. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene. Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121 [TBL] [Abstract][Full Text] [Related]
2. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line. Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947 [TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen. Besser D; Urich M; Sakaue M; Messerschmitt A; Ballmer-Hofer K; Nagamine Y Oncogene; 1995 Dec; 11(11):2383-91. PubMed ID: 8570190 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the uPA gene in various grades of human glioma cells. Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541 [TBL] [Abstract][Full Text] [Related]
5. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Besser D; Presta M; Nagamine Y Cell Growth Differ; 1995 Aug; 6(8):1009-17. PubMed ID: 8547215 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Besser D; Bardelli A; Didichenko S; Thelen M; Comoglio PM; Ponzetto C; Nagamine Y Oncogene; 1997 Feb; 14(6):705-11. PubMed ID: 9038378 [TBL] [Abstract][Full Text] [Related]
8. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882 [TBL] [Abstract][Full Text] [Related]
9. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. Lengyel E; Stepp E; Gum R; Boyd D J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439 [TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Tong L; Smyth D; Kerr C; Catterall J; Richards CD Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Gum R; Wang SW; Lengyel E; Yu D; Hung MC; Juarez J; Boyd D Anticancer Res; 1995; 15(4):1167-72. PubMed ID: 7653995 [TBL] [Abstract][Full Text] [Related]
12. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Cuevas BD; Uhlik MT; Garrington TP; Johnson GL Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021 [TBL] [Abstract][Full Text] [Related]
13. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product. Schönthal A; Feramisco JR New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599 [TBL] [Abstract][Full Text] [Related]
14. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor. Yue J; Sun B; Liu G; Mulder KM J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011 [TBL] [Abstract][Full Text] [Related]
15. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743 [TBL] [Abstract][Full Text] [Related]
16. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
17. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197 [TBL] [Abstract][Full Text] [Related]
18. Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos. Pham CD; Vuyyuru VB; Yang Y; Bai W; Singh B Oncogene; 1999 Jul; 18(30):4287-94. PubMed ID: 10439036 [TBL] [Abstract][Full Text] [Related]
19. Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells. Okada Y; Voznesensky O; Herschman H; Harrison J; Pilbeam C J Cell Biochem; 2000 May; 78(2):197-209. PubMed ID: 10842315 [TBL] [Abstract][Full Text] [Related]